ASPET Comment Letter to NIH RFI on Novel Alternative Methods

ASPET Statement in Response to FY2024 Appropriations Process

ASPET Comment on NIH Grant Proposal

FY2023 Funding Overview

CHIPS and Science Act authorizes effectively doubling NSF budget by FY27

ASPET signs letter to Senate urging that the Director of the White House Office of Science and Technology Policy be considered promptly.

The federation of biomedical associations encouraged flexibility be provided for conducting animal program reviews.

Along with 46 other biomedical societies, ASPET signed on to an Animal Research Sign-on Letter Regarding FY23 Appropriations.

Along with more than 25 other leading health organizations, ASPET joins Women’s Health Access Matters (WHAM) in calling for Congress to accelerate women’s health research, especially for diseases that disproportionately affect women.

Along with nearly 400 other organizations and institutions, ASPET endorses the recommendation of the Ad Hoc Group for Medical Research.

ASPET and FOVA Recommendations for FY 2023, Department of Veterans Affairs

The purpose of the plan is to articulate NIH’s vision for embracing, integrating, and strengthening DEIA at NIH.

The letter follows demands from several members of Congress that NIH stop funding studies using animal models.

The current continuing resolution funding the government at FY21 levels expires on February 18.

The proposal contains provisions that will streamline the process for conducting research with Schedule I drugs

The $904m appropriation will ensure continuation of the best medical research for our veterans.

The figure represents the higher of the two appropriations numbers for the agency put forward by the House and Senate.

The recommendations include a focus on pandemic readiness and prevention and STEM education.

Continuing resolutions stall progress and impede our ability to make scientific and technological advances

The draft includes an authorization for the creation of ARPA-H and research relief funding via the RISE Act.